Donald Engelman

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Donald Max Engelman
Website medicine.yale.edu/lab/engelman/
Scientific career
Thesis Solubilization and Aggregatino Properties of Membrane Components from Mycoplasma Laidlawii (1968)
Doctoral students Mark A. Lemmon[1][2]

Donald Max Engelman (born 1941) is Higgins Professor of Biochemistry at Yale University. He is a member of the National Academy of Sciences (1997), fellow of the American Academy of Arts and Sciences,[3] a fellow of the National Institutes of Health, and has been a Guggenheim fellow.[4] He is a director of the Stryker Corporation.[5] He is involved in the creation of new cancer drugs and treatments.[6] For example, Engelman is involved in research to use peptides to aid in destroying tumors.[7]

Administration, Advising, and Consulting[edit]

Engelman has served as Director of Biological Sciences at Yale, an advisor to the Brookhaven National Laboratory, and a consultant to the Los Alamos National Laboratory.[8] He also served as Acting Dean of Yale College in 1991.[9]

Education[edit]

Engelman is a graduate (and trustee[10]) of Reed College and Yale University.[11]

Engelman Lab[edit]

Engelman directs the Engelman Laboratory at Yale.[12]

Patents[edit]

Engelman holds six United States patents for his discoveries.[13]

References[edit]

  1. ^ Lemmon, Mark A.; Flanagan, John M.; Treutlein, Herbert R.; Zhang, Jian; Engelman, Donald M. (1992). "Sequence specificity in the dimerization of transmembrane .alpha.-helixes". Biochemistry. 31 (51): 12719–12725. doi:10.1021/bi00166a002. PMID 1463743. 
  2. ^ Lemmon, Mark Andrew (1993). Specific interactions between transmembrane alpha-helices: Their role in the oligomerization of integral membrane proteins (PhD thesis). Yale University.  (subscription required)
  3. ^ "REED COLLEGE AMERICAN ACADEMY OF ARTS AND SCIENCES AWARDS". 
  4. ^ "All Fellows - John Simon Guggenheim Memorial Foundation". Gf.org. Retrieved 2011-07-06. 
  5. ^ "Donald M. Engelman Profile - Forbes.com". People.forbes.com. Retrieved 2011-07-06. 
  6. ^ redOrbit. "URI Research Couple's Method Targets Cancerous Tumors - Redorbit". Redorbit. 
  7. ^ http://www.healthimaging.com/index.php?option=com_articles&article=19339
  8. ^ "Reed Magazine: News of the College". 
  9. ^ "A Yale College Dean Is Named". The New York Times. 1991-10-15. 
  10. ^ "List of Public Companies Worldwide, Letter - Businessweek - Businessweek". Businessweek.com. 
  11. ^ "The Engelman Lab - Donald M. Engelman". Yale.edu. Retrieved 2011-07-06. 
  12. ^ "The Engelman Lab". Yale.edu. Retrieved 2011-07-06. 
  13. ^ "Donald M Engelman, Page 1".